logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Cambridge Neuroscience, Inc.


USPTO Granted Patents = 43


Forward Citations = 482

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Lain-Yen Hu (23 out of 25 patents)

silverMedal Stanley M Goldin (21 out of 24 patents)

bronzeMedal James B Fischer (19 out of 21 patents)

4.  N Laxma Reddy (19 out of 24 patents)

5.  Andrew Gannett Knapp (18 out of 21 patents)

6.  Subbarao Katragadda (18 out of 20 patents)

7.  Lee David Margolin (16 out of 16 patents)

8.  Graham J Durant (15 out of 29 patents)

9.  Sharad S Magar (13 out of 18 patents)

10.  Andrew David Goodearl (7 out of 20 patents)

11.  Luisa Minghetti (7 out of 19 patents)

12.  Paul Stroobant (7 out of 20 patents)

13.  Michael Derek Waterfield (7 out of 31 patents)

14.  Ian D Hiles (7 out of 24 patents)

15.  Mark Marchioni (6 out of 15 patents)


Core Competencies:
Therapeutic Guanidines
Pharmaceutically Active Compounds
Glial Mitogenic Factors
Sigma Receptor Ligands
Neuregulins
Aminoguanidines
Hydrazinedicarboximidamide Compounds
Calcium Channel Antagonists
Substituted Guanidines
Cellular Communication
Eye Trauma Treatment
Drug Delivery Devices

43 patents:

1. 6787569 - Therapeutic guanidines (2004-09-07),
2. 6774263 - Pharmaceutically active compound and methods of use (2004-08-10),
3. 6756389 - Pharmaceutically active compounds and methods of use (2004-06-29),
4. 6242198 - Methods of treatment of eye trauma and disorders (2001-06-05),
5. 6232061 - Homology cloning (2001-05-15),
6. 6174924 - Therapeutic guanidines (2001-01-16),
7. 6156741 - Therapeutic substituted guanidines (2000-12-05),
8. 6153604 - Therapeutic substituted guanidines (2000-11-28),
9. 6147190 - Glial mitogenic factors, their preparation and use (2000-11-14),
10. 6147063 - Therapeutic substituted guanidines (2000-11-14),
11. 6143791 - Therapeutic guanidines (2000-11-07),
12. 6087346 - Sigma receptor ligands and the use thereof (2000-07-11),
13. 6087323 - Use of neuregulins as modulators of cellular communication (2000-07-11),
14. 6071969 - Substituted aminoguanidines and methods of use thereof (2000-06-06),
15. 6025355 - Pharmaceutically active compounds and methods of use (2000-02-15),
Cambridge Neuroscience, Inc. is a leading research company specializing in neuroscience. Our dedicated team of scientists and researchers work tirelessly to unravel the mysteries of the brain and develop innovative solutions to improve neurological health. With a strong focus on cutting-edge technologies and cross-disciplinary collaborations, we strive to make breakthrough discoveries in areas such as neurodegenerative diseases, neural pathways, and cognitive functions. Visit our website to learn more about our ongoing projects, publications, and career opportunities.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#53 in Cambridge, MA

#452 in Massachusetts

#7,821 in US

#15,578 in the World

...
Cambridge, MA, United States of America

Cambridge Neuroscience, Inc.

Forward Citations = 482

40 inventors:

goldMedal Lain-Yen Hu (23 out of 25 patents)

silverMedal Stanley M Goldin (21 out of 24 patents)

bronzeMedal James B Fischer (19 out of 21 patents)

4.  N Laxma Reddy (19 out of 24 patents)

5.  Andrew Gannett Knapp (18 out of 21 patents)

Please report any incorrect information to support@idiyas.com
Loading…